Horton C D, Halvorson L M
Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9032, USA.
J Mol Endocrinol. 2004 Feb;32(1):291-306. doi: 10.1677/jme.0.0320291.
Expression of the gonadotropin genes has been shown to be modulated by pharmacological or physiological activators of both the protein kinase C (PKC) and the cAMP second messenger signaling pathways. Over the past few years, a substantial amount of progress has been made in the identification and characterization of the transcription factors and cognate cis-elements which mediate the PKC response in the LH beta-subunit (LHbeta) gene. In contrast, little is known regarding the molecular mechanisms which mediate cAMP-mediated regulation of this gene. Using pituitary cell lines, we now demonstrate that rat LHbeta gene promoter activity is stimulated following activation of the cAMP system by the adenylate cyclase activating agent, forskolin, or by the peptide, pituitary adenylate cyclase-activating peptide. The forskolin response was eliminated with mutation of a previously identified 3' cis-acting element for the early growth response protein-1 (Egr-1) when evaluated in the context of region -207/+5 of the LHbeta gene. Activation of the cAMP system increased Egr-1 gene promoter activity, Egr-1 protein levels and Egr-1 binding to the LHbeta gene promoter, supporting the role of this transcription factor in mediating the cAMP response. Analysis of a longer LHbeta promoter construct (-797/+5) revealed additional contribution by upstream Sp1 DNA-regulatory regions. Of interest, forskolin-induced stimulation of LHbeta gene promoter activity was observed to increase synergistically with introduction of the transcription factor, steroidogenic factor-1 (SF-1). Although SF-1 is a critical mediator of the cAMP response in other genes, mutation of the SF-1 DNA-binding sites in the rat LHbeta gene did not alter the forskolin response nor did forskolin increase SF-1 protein levels in a gonadotrope cell line. In a further set of experiments, it was determined that forskolin-responsiveness was maintained following mutation of the previously defined homeobox-binding element at position -100. We conclude that both Egr-1 and Sp1 contribute to cAMP-dependent transcription of the rat LHbeta gene promoter. While SF-1 does not act independently to mediate the cAMP/PKA response, SF-1 is important for magnification of this response.
促性腺激素基因的表达已被证明可受到蛋白激酶C(PKC)和cAMP第二信使信号通路的药理学或生理学激活剂的调节。在过去几年中,在鉴定和表征介导LHβ亚基(LHbeta)基因中PKC反应的转录因子和同源顺式元件方面取得了大量进展。相比之下,关于介导该基因cAMP介导调节的分子机制知之甚少。利用垂体细胞系,我们现在证明,在用腺苷酸环化酶激活剂福斯可林或肽垂体腺苷酸环化酶激活肽激活cAMP系统后,大鼠LHbeta基因启动子活性受到刺激。当在LHbeta基因的-207 / +5区域的背景下评估时,福斯可林反应因先前鉴定的早期生长反应蛋白-1(Egr-1)的3'顺式作用元件的突变而消除。cAMP系统的激活增加了Egr-1基因启动子活性、Egr-1蛋白水平以及Egr-1与LHbeta基因启动子的结合,支持了该转录因子在介导cAMP反应中的作用。对更长的LHbeta启动子构建体(-797 / +5)的分析揭示了上游Sp1 DNA调节区域的额外贡献。有趣的是,观察到随着转录因子类固醇生成因子-1(SF-1)的引入,福斯可林诱导的LHbeta基因启动子活性刺激协同增加。尽管SF-1是其他基因中cAMP反应的关键介质,但大鼠LHbeta基因中SF-1 DNA结合位点的突变并未改变福斯可林反应,福斯可林也未增加促性腺激素细胞系中的SF-1蛋白水平。在另一组实验中,确定在-100位先前定义的同源框结合元件发生突变后,福斯可林反应性得以维持。我们得出结论,Egr-1和Sp1都有助于大鼠LHbeta基因启动子的cAMP依赖性转录。虽然SF-1并不独立发挥作用来介导cAMP / PKA反应,但SF-1对于放大该反应很重要。